ASCO 2026: Novel CD5 directed CAR-T therapy for T-ALL/PTCL shows mixed response

Patients with T-cell acute lymphoblastic leukaemia (T-ALL) and the closely related peripheral T-cell lymphoblastic lymphoma ...
Everyday Health

What to Expect When Starting CAR T-Cell Therapy for Large B-Cell Lymphoma

I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...
Phys.org

Lipid nanoparticles that engineer CAR T cells in vivo could unlock access for millions of autoimmune patients

Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted ...
C&EN

mRNA-based therapy creates CAR-T immune cells within the body

The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more. Current approved CAR T-cell therapy treatments rely ...

PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas ...

PeproMene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor (BAFF-R)-targeted CAR T-cell ...
MedPage Today on MSN

CAR T-cell trial in rheumatoid arthritis starts off strong

Strong initial responses in 4 of 6 patients after many standard drugs had failed ...